Key Takeaways
July 25, 2026 · 3 min read · By Rishabh Bhardwaj
·
AI-assisted, human-reviewed · Our editorial standards
A clutch of listed Indian companies will report their April-June 2026 quarter earnings today, July 25, 2026, covering banking, pharmaceuticals, defence technology, and building materials. The results will offer early signals on how corporate India is tracking through the first quarter of financial year 2027.
AU Small Finance Bank and IDFC First Bank are the most closely watched names on the list. Both are mid-sized lenders whose numbers will be read as a gauge of retail credit demand, deposit mobilisation, and asset quality in the current rate environment. Investors will pay particular attention to net interest margins and any commentary on slippages, given ongoing scrutiny of small finance bank stress in select unsecured loan segments.
SBFC Finance, a small business-focused non-bank lender, adds another lens on credit conditions for micro and small enterprises. Its loan book growth and collection efficiency will indicate how the self-employed borrower segment is holding up.
Dr. Reddy's Laboratories is the headline name from pharma. As one of India's larger generic drug exporters, its numbers will reflect US generics pricing trends, domestic formulations growth, and any currency tailwinds or headwinds from the rupee-dollar movement in the June quarter. Investors will watch for guidance on new product launches and any regulatory updates from the US Food and Drug Administration.
Zen Technologies, a defence simulation and training company, has drawn investor interest on the back of India's push to expand domestic defence procurement. Its Q1 FY27 order book disclosures and revenue recognition pace will be watched closely by investors tracking the listed defence technology space.
Birla Corporation rounds out the list from the cement and building materials sector. Cement companies faced a mixed first quarter, with volume growth in some regions offset by pricing pressure. Birla Corporation's realisation per tonne and cost structure will be compared against peers who have already reported.
For the two banks and SBFC Finance, the key variables are net interest income growth, credit costs, and deposit growth rates. Any deterioration in asset quality or a squeeze on margins could weigh on their share prices when markets open on Monday.
For Dr. Reddy's, the US business remains the swing factor. A stable or improving US generics price environment would support earnings, while any plant inspection observations or pricing erosion would do the opposite.
Zen Technologies investors will focus on whether order inflows and revenue are accelerating in line with India's rising defence capital expenditure budgets, which have expanded significantly over recent years.
Birla Corporation's results come at a time when the cement sector is watching demand recovery from the construction and infrastructure pipeline. Input cost trends, particularly for pet coke and coal, will shape the margin story for the quarter.
Management commentary across all six companies will be as important as the headline numbers. Guidance on the rest of FY27, capital allocation plans, and any stress flags in loan books or order pipelines will drive near-term stock moves. Results will be published to the stock exchanges in line with SEBI disclosure timelines, typically after market hours or during the trading day.
The Dow, S&P 500, and Nasdaq struggled for direction on July 24, 2026, as a tech-sector rout and new Trump tariffs arriving simultaneously unsettled investors. The dual pressure raises margin concerns for import-heavy companies and clouds near-term earnings guidance across major indices.
Rekha Jhunjhunwala sold roughly 7.38 crore Star Health shares in FY27, cutting her stake from 15.5% to 3.04% and erasing the promoter holding entirely by June 30, 2026. The stock fell over 1%, and Star Health now has no promoter on record, raising governance and institutional ownership questions.
The Dow, S&P 500, and Nasdaq all fell on July 24, 2026, as rising oil prices pressured sentiment. Investors were also holding back ahead of major earnings reports from Alphabet and Tesla, two of the heaviest-weighted names in U.S. indexes.
Swiggy shares fell more than 7% on July 24, 2026, nearing a record low after the company proposed capping foreign ownership at 49.5%. The move risks triggering passive fund outflows and possible removal from global indices, compounding a 41% decline over the past year.